Insights from 2023 SABCS

Videos
20:25

Insights from 2023 SABCS

SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for Premenopausal Women"

FEATURING Vered Stearns
  • 479 views
  • March 2, 2024
  • 2
08:23

Insights from 2023 SABCS

SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapine With Triple Antiemetic Therapy for Prevention of Highly Emetogenic Chemo-Induced Nausea & Vomiting in Solid Tumors"

FEATURING Jyoti Bajpai
  • 72 views
  • February 28, 2024
  • 1
12:21

Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

FEATURING Priyanka Sharma
  • 601 views
  • January 22, 2024
  • 4
23:33

Insights from 2023 SABCS

SABCS 2023 Insights: "The Role for Dato-DXd in HR+ mBC"

FEATURING Sara Tolaney, Hope Rugo
  • 407 views
  • January 22, 2024
  • 2
26:30

Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & HER2CLIMB-02 Trials"

FEATURING Sara Tolaney, Hope Rugo
  • 420 views
  • January 22, 2024
  • 2
13:33

Insights from 2023 SABCS

SABCS 2023 Insights: "PREFERABLE-EFFECT Study - Effects of a Structured & Individualized Exercise Program on Fatigue and Health-Related QoL in Patients With mBC"

FEATURING Anouk Hiensch
  • 64 views
  • January 17, 2024
  • 1
08:07

Insights from 2023 SABCS

SABCS 2023 Insights: "Protocol-Defined Biomarker Analysis in the PALLAS Adjuvant Trial - Genomic Subtype Derived From RNA Sequencing of HR+/HER2- eBC"

FEATURING Daniel Stover
  • 59 views
  • January 17, 2024
17:18

Insights from 2023 SABCS

SABCS 2023 Insights: "ELECTRA Study of Elacestrant in Combination With Abemaciclib in Patients With Brain Mets From ER+/HER2- BC"

FEATURING Nuhad Ibrahim
  • 239 views
  • January 17, 2024
27:52

Insights from 2023 SABCS

SABCS 2023 Insights: "Innovative Approaches at the Diagnosis and Treatment of Invasive Lobular Carcinoma"

FEATURING Jason Mouabbi
  • 261 views
  • January 3, 2024
  • 2
09:41

Insights from 2023 SABCS

SABCS 2023 Insights: "ADAPTcycle Trial - Impact of Age and Ovarian Function Suppression on Endocrine Response to Short Preoperative ET for BC"

FEATURING Oleg Gluz
  • 828 views
  • January 3, 2024
  • 5
29:40

Insights from 2023 SABCS

Year in Review: Metastatic Breast Cancer

FEATURING Mariana Chavez Mac Gregor
  • 1,033 views
  • January 3, 2024
  • 10
10:14

Insights from 2023 SABCS

SABCS 2023 Insights: "A Study of RGT-419B, a Next-Gen CDK4 Inhibitor, in Pts With HR+/HER2- Advanced or Metastatic BC Who Progressed on Prior CDK4/6i"

FEATURING Seth Wander
  • 238 views
  • January 3, 2024
  • 4
04:30

Insights from 2023 SABCS

SABCS 2023 Insights: "VERITAC-3 Study, With a Lead-in, of 1L Vepdegestrant + Palbociclib vs. Letrozole + Palbociclib in ER+/HER2- Advanced BC"

FEATURING Seth Wander
  • 186 views
  • January 3, 2024
  • 1
14:00

Insights from 2023 SABCS

SABCS 2023 Insights: "CDK4/6 Inhibition as a Potential Vulnerability in NF1-Depleted ER+ Breast Cancer"

FEATURING Eric Chang
  • 98 views
  • January 3, 2024
  • 2
08:45

Insights from 2023 SABCS

SABCS 2023 Insights: "OPERA-01 Study of Palazestrant vs. Standard-of-Care Treatment for ER+, HER2- Advanced or mBC After ET & CDK4/6i"

FEATURING Arlene Chan
  • 106 views
  • January 3, 2024
  • 1
11:28

Insights from 2023 SABCS

SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk Breast Cancer During Adjuvant Endocrine Therapy"

FEATURING Lajos Pusztai
  • 1,632 views
  • January 2, 2024
  • 9
08:41

Insights from 2023 SABCS

SABCS 2023 Insights: "Analysis of ctDNA for the Detection of MRD Using a Tissue-Free, Multiomic Assay in Pts With Early Stage Breast Cancer"

FEATURING Wolfgang Janni
  • 847 views
  • January 2, 2024
  • 4
15:13

Insights from 2023 SABCS

SABCS 2023 Insights: "5-Year Outcomes of the IDEA Trial - ET Without RT After Breast-Conserving Surgery for Postmenopausal Patients Age 50-69 With Genomically-Selected Favorable Stage I BC"

FEATURING Reshma Jagsi
  • 515 views
  • December 21, 2023
  • 4
03:37

Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in Early Stage TNBC?"

FEATURING Sara Tolaney, Hope Rugo
  • 434 views
  • December 21, 2023
  • 6
14:01

Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for IO in Early Stage High Risk ER+ BC?"

FEATURING Sara Tolaney, Hope Rugo
  • 573 views
  • December 21, 2023
  • 4
10:27

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuvant eBC Setting?"

FEATURING Sara Tolaney, Hope Rugo
  • 1,526 views
  • December 21, 2023
  • 8
08:54

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for Patients With HR+ mBC With Early Relapse and a PI3Km?"

FEATURING Sara Tolaney, Hope Rugo
  • 478 views
  • December 21, 2023
  • 2
12:35

Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+ mBC?"

FEATURING Sara Tolaney, Hope Rugo
  • 3,013 views
  • December 21, 2023
  • 17
04:18

Insights from 2023 SABCS

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebrospinal Fluid, Peripheral Blood, and Systemic Metastatic Tumor Tissue of Patients With mBC and LMD"

FEATURING Laura Huppert
  • 264 views
  • December 20, 2023
  • 2
05:48

Insights from 2023 SABCS

SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in Patients With HER2-Low mBC"

FEATURING Laura Huppert
  • 220 views
  • December 20, 2023
  • 2
09:19

Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for Premenopausal Women With Nodal Involvement, but Low Genomic Prognostic Assay"

FEATURING Kevin Kalinsky
  • 1,776 views
  • December 19, 2023
  • 9
03:04

Insights from 2023 SABCS

SABCS 2023 Insights: "The Future of Oral SERDs in Breast Cancer"

FEATURING Erika Hamilton
  • 439 views
  • December 19, 2023
  • 4
03:03

Insights from 2023 SABCS

SABCS 2023 Insights: "CAMBRIA 1 Study of Extended Adjuvant Therapy With Camizestrant vs. Standard ET in Patients With ER+/HER2- Early BC and an Intermediate/High Risk of Recurrence"

FEATURING Erika Hamilton
  • 379 views
  • December 19, 2023
  • 3
02:27

Insights from 2023 SABCS

SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib or Placebo in Combination With Trastuzumab & Pertuzumab as Maintenance Therapy for HER2+ mBC"

FEATURING Erika Hamilton
  • 268 views
  • December 19, 2023
04:03

Insights from 2023 SABCS

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"

FEATURING Marta Vaz Batista
  • 178 views
  • December 18, 2023
  • 3
17:35

Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-02"

FEATURING Paolo Tarantino
  • 1,077 views
  • December 18, 2023
  • 7
10:56

Insights from 2023 SABCS

SABCS 2023 Insights: "CompassHER2 RD Trial - Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients With Residual HER2+ Invasive BC"

FEATURING Ciara O'Sullivan
  • 312 views
  • December 15, 2023
  • 2
05:40

Insights from 2023 SABCS

SABCS 2023 Insights: "CONFIDENT-B Trial - Clinical Implementation of AI-Assisted Detection of BC Metastases in Sentinel Lymph Nodes"

FEATURING Carmen Dooijeweert
  • 243 views
  • December 15, 2023
07:01

Insights from 2023 SABCS

SABCS 2023 Insights: "Clinical Risk Score to Predict Overall Survival and BC Recurrence in TAILORx Trial and the SEER Database Populations"

FEATURING Sherry Yang
  • 712 views
  • December 15, 2023
  • 2
12:48

Insights from 2023 SABCS

SABCS 2023 Insights: "POSITIVE Trial - Fertility Preservation and Assisted Reproductive Technologies in BC Patients Interrupting ET to Attempt Pregnancy"

FEATURING Hatem Azim
  • 212 views
  • December 15, 2023
  • 1
13:01

Insights from 2023 SABCS

SABCS 2023 Insights: "Final iDFS Analysis From the NATALEE Trial - Ribociclib + NSAI as Adjuvant Treatment in Patients With HR+/HER2- eBC"

FEATURING Gabriel Hortobagyi
  • 499 views
  • December 15, 2023
  • 4
09:46

Insights from 2023 SABCS

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Various Combinations in Patients With ER+, HER2- Locally Advanced or mBC"

FEATURING Hope Rugo
  • 148 views
  • December 15, 2023
  • 1
14:15

Insights from 2023 SABCS

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pembro + Chemo After Induction With Pembro + Chemo for Locally Recurrent Inoperable or Metastatic TNBC"

FEATURING Hope Rugo
  • 330 views
  • December 15, 2023
  • 6
08:24

Insights from 2023 SABCS

SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigating Capivasertib and Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"

FEATURING Hope Rugo
  • 610 views
  • December 15, 2023
  • 2
26:50

Insights from 2023 SABCS

SABCS 2023 Insights: "Controversies in the Surgical Management of Inflammatory BC"

FEATURING Anthony Lucci
  • 167 views
  • December 15, 2023
  • 2
04:09

Insights from 2023 SABCS

SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertuzumab & Trastuzumab According to Estrogen Receptor and HER2 Expression"

FEATURING Elisa Agostinetto
  • 299 views
  • December 13, 2023
  • 2
14:59

Insights from 2023 SABCS

SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial - Loco-Regional Irradiation in Patients With Biopsy-Proven Axillary Node Involvement at Presentation Who Become Pathologically Node- After Neoadjuvant Chemo"

FEATURING Terry Mamounas
  • 1,114 views
  • December 13, 2023
  • 8
12:50

Insights from 2023 SABCS

SABCS 2023 Insights: "5-Year Clinical Outcomes of ECOG-AGRIN 4112 Trial - Magnetic Resonance Imaging and a 12-Gene Expression Assay to Optimize Local Therapy for Ductal Carcinoma in Situ"

FEATURING Seema Khan
  • 189 views
  • December 13, 2023
  • 4
04:35

Insights from 2023 SABCS

SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib + Fulvestrant +/- Palbociclib in Patients With HR+/ HER2- aBC Previously Treated With CDK4/6i + Non-Steroidal Aromatase Inhibitor"

FEATURING Sara A. Hurvitz
  • 333 views
  • December 12, 2023
  • 2
09:52

Insights from 2023 SABCS

SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Trastuzumab Emtansine for Previously Treated HER2+ mBC"

FEATURING Sara A. Hurvitz
  • 353 views
  • December 12, 2023
  • 4